Who Paid My Doc
Iov-Eap-402
Research payments
$282,191
Through program year 2025, $282,191 in research payments was reported against Iov-Eap-402, across 40 payments, paid by Iovance Biotherapeutics, Inc..
- Paid by
- Iovance Biotherapeutics, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $262,191 | 34 |
| 2024 | Research | $20,000 | 6 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Matthew Frigault Boston, MA Named on 5 payments
- Allison Betof Warner Stanford, CA Named on 4 payments
- William Sharfman Lutherville, MD Named on 3 payments
- George Ansstas Saint Louis, MO Named on 2 payments
- Alexander Shoushtari New York, NY Named on 2 payments
- Caroline Nebhan Murray, UT Named on 2 payments
- Geoffrey Gibney Washington, DC Named on 2 payments
- Jason Chesney Louisville, KY Named on 2 payments
- Melissa Wilson Easton, PA Named on 2 payments
- Michael Hurwitz New Haven, CT Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.